Evidence map›Paper›PMID 41446058›Full record

ArticlebioRxiv : the preprint server for biology2025

Antibody Mediated Diversification of Primary and Secondary Immune Responses.

Dennis Schaefer-Babajew, Laurine Binet, Gabriela S Silva Santos, Chiara Ruprecht, Lachlan P Deimel, Mohamed A ElTanbouly, Dounia Gharrassi, Clara Uhe, Kai-Hui Yao, Brianna Hernandez and 5 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Dennis Schaefer-BabajewLaboratory of Molecular Immunology, Rockefeller University; New York, NY, USA.ORCID 0000-0002-5380-2950
Laurine BinetLaboratory of Molecular Immunology, Rockefeller University; New York, NY, USA.ORCID 0009-0005-3260-8891
Gabriela S Silva SantosLaboratory of Molecular Immunology, Rockefeller University; New York, NY, USA.ORCID 0000-0002-7482-7380
Chiara RuprechtLaboratory of Molecular Immunology, Rockefeller University; New York, NY, USA.
Lachlan P DeimelLaboratory of Molecular Immunology, Rockefeller University; New York, NY, USA.ORCID 0000-0003-3803-871X
Mohamed A ElTanboulyLaboratory of Molecular Immunology, Rockefeller University; New York, NY, USA.ORCID 0000-0001-7985-3839
Dounia GharrassiLaboratory of Molecular Immunology, Rockefeller University; New York, NY, USA.
Clara UheLaboratory of Molecular Immunology, Rockefeller University; New York, NY, USA.
Kai-Hui YaoLaboratory of Molecular Immunology, Rockefeller University; New York, NY, USA.
Brianna HernandezLaboratory of Molecular Immunology, Rockefeller University; New York, NY, USA.
Parul AgrawalFred Hutchinson Cancer Center, Seattle, WA, USA.
Anna GazumyanLaboratory of Molecular Immunology, Rockefeller University; New York, NY, USA.ORCID 0000-0002-5976-9717
Leonidas StamatatosFred Hutchinson Cancer Center, Seattle, WA, USA.ORCID 0000-0002-1106-7097
Harald HartwegerLaboratory of Molecular Immunology, Rockefeller University; New York, NY, USA.ORCID 0000-0002-1118-1818
Michel C NussenzweigLaboratory of Molecular Immunology, Rockefeller University; New York, NY, USA.ORCID 0000-0003-0592-8564

Funding

Identification of neutralizing epitopes on SARS-CoV-2 spike for design of vaccines and small-molecule antiviralsUM1AI144462 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI BURTON, DENNIS R. · 2019 to 2025
$201.6M
Stuctural basis of bNab activityP01AI100148 · NIAID · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI Pamela J Bjorkman · 2013 to 2026
$43.3M
Developing, Demonstrating, and Disseminating Innovative Programs to Achieve Translational SuccessUL1TR001866 · NCATS · ROCKEFELLER UNIVERSITY · PI COLLER, BARRY, KRUEGER, JAMES G · 2016 to 2025
$40.6M
INSPIRE: Innovative Strategies for Personalized Immunotherapies and Reservoir EradicationUM1AI191237 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI Marina Caskey, R. Brad Jones · 2025 to 2026
$5.9M
NCATS NIH HHS UL1 TR001866NIAID NIH HHS P01 AI100148NIAID NIH HHS UM1 AI144462NIAID NIH HHS UM1 AI191237
6 · The paper itself

Abstract

Humoral immune responses are characterized by increasing antibody affinity and diversity over time. Increased affinity is mediated by a combination of immunoglobulin gene somatic mutation and iterative cycles of selection in germinal centers. Less is understood about how diversity increases in parallel with affinity. Here we examine the role of antibody feedback in diversifying immune responses in mice that produce B cells that are incapable of secreting antibodies. To this end, we produced two strains of mice, one that expresses only membrane and secreted forms of IgM, and a second that produces only the membrane bound form of IgM. Analysis of primary and secondary immune responses show that antibody feedback significantly diversifies both primary and secondary immune responses even when antibodies are present at levels that are 10-30 fold lower than physiologic. The data have significant implication for sequential vaccination approaches aimed at shepherding immunity to produce broadly neutralizing antibodies to highly diversified pathogens such as HIV-1 and Influenza.

Identifiers

PMID41446058
PMCPMC12724515

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.